Export 2 results:
Autore Titolo Tipo [ Anno
Filtri: Autore è Celeghini, Claudio and First Letter Of Title is A [Clear All Filters]
Anti-leukemic activity of dasatinib in both p53(wild-type) and p53(mutated) B malignant cells. Invest New Drugs 2012;30(1):417-22.
. .